Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12533425 | Methods and systems using peptides for targeting and mapping human nerves in image guided surgery, diagnostics and therapeutic delivery | 🖼🧊📄§ | 2026-01-27 | 2040-10-09 | 0 | 31 |
| 12533360 | Inhibition of BRD proteins suppresses the phenotype of uterine fibroids | 🖼🧊📄§ | 2026-01-27 | 2042-10-18 | 0 | 31 |
| 12533401 | Devices and methods for modulating ADMA in blood | 🖼🧊📄§ | 2026-01-27 | 2040-09-10 | 0 | 31 |
| 12533414 | Protein L for activation and expansion of chimeric antigen receptor-modified immune cells | 🖼🧊📄§ | 2026-01-27 | 2039-09-19 | 0 | 31 |
| 12534518 | Fusion protein comprising anti-mesothelin antibody, anti-CD3 antibody or anti-EGFR antibody, bispecific or trispecific antibody comprising same, and uses thereof | 🖼🧊📄§ | 2026-01-27 | 2039-12-16 | 0 | 31 |
| 12533408 | Treatment regimen for the treatment of autoimmune disorders | 🖼🧊📄§ | 2026-01-27 | 2044-06-20 | 0 | 31 |
| 12533376 | Prophylactic or therapeutic agent for disease induced by oxidative stress | 🖼🧊📄§ | 2026-01-27 | 2040-12-07 | 0 | 31 |
| 12533340 | Treatment of autoimmune disease in a patient receiving additionally a beta-blocker | 🖼🧊📄§ | 2026-01-27 | 2043-07-14 | 0 | 31 |
| 12533404 | Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases | 🖼🧊📄§ | 2026-01-27 | 2041-04-28 | 0 | 31 |
| 12533389 | Glycopeptide antibiotic combination therapy | 🖼🧊📄§ | 2026-01-27 | 2042-07-26 | 0 | 31 |
| 12533444 | Mitigation of peri-implantitis by design and stability of bifunctional peptides with antimicrobial properties | 🖼🧊📄§ | 2026-01-27 | 2040-09-07 | 0 | 31 |
| 12534713 | Chimeric alkaline phosphatase-like proteins | 🖼🧊📄§ | 2026-01-27 | 2043-05-30 | 0 | 31 |
| 12533397 | Methods of treating ATPase-mediated diseases with a nucleic acid encoding ATP1A3 and a neuron-specific promoter | 🖼🧊📄§ | 2026-01-27 | 2043-06-23 | 0 | 31 |
| 12534537 | Anti-CD38 antibody and methods of use thereof | 🖼🧊📄§ | 2026-01-27 | 2040-06-26 | 0 | 31 |
| 12533338 | Enhanced gene delivery to natural killer cells, hematopoietic stem cells and macrophages | 🖼🧊📄§ | 2026-01-27 | 2036-09-30 | 0 | 31 |
| 12533333 | Method of treatment of obesity | 🖼🧊📄§ | 2026-01-27 | 2044-05-29 | 0 | 31 |
| 12533358 | Methods of treatment with elinzanetant | 🖼🧊📄§ | 2026-01-27 | 2045-05-14 | 0 | 31 |
| 12534520 | YKL-40-targeting human monoclonal antibody | 🖼🧊📄§ | 2026-01-27 | 2040-09-07 | 0 | 31 |
| 12533412 | Ultrasound-responsive liposome nanoparticles and preparation method and use thereof | 🖼🧊📄§ | 2026-01-27 | 2042-10-13 | 0 | 31 |
| 12533366 | Low dose therapeutic treatment | 🖼🧊📄§ | 2026-01-27 | 2043-10-12 | 0 | 31 |
| 12533359 | Method for preventing hair loss | 🖼🧊📄§ | 2026-01-27 | 2040-07-02 | 0 | 31 |
| 12533386 | Preparation of black tea extract with high theaflavin content and use thereof | 🖼🧊📄§ | 2026-01-27 | 2042-11-06 | 0 | 31 |
| 12534709 | Shaped organoid compositions and methods of making same | 🖼🧊📄§ | 2026-01-27 | 2040-05-29 | 0 | 31 |
| 12533353 | Methods of treatment of cancer comprising CDC7 inhibitors | 🖼🧊📄§ | 2026-01-27 | 2039-08-28 | 0 | 31 |
| 12533415 | Core/shell structure platform for immunotherapy | 🖼🧊📄§ | 2026-01-27 | 2042-05-24 | 0 | 31 |
| 12533342 | Methods of treating bacterial infections | 🖼🧊📄§ | 2026-01-27 | 2042-05-27 | 0 | 31 |
| 12534442 | Benzisoxazole derivative | 🖼🧊📄§ | 2026-01-27 | 2041-07-06 | 0 | 31 |
| 12534532 | CLL1-targeting antibody and application thereof | 🖼🧊📄§ | 2026-01-27 | 2039-10-28 | 0 | 31 |
| 12533356 | Pyrazolopyrimidine compounds as adenosine receptor antagonists | 🖼🧊📄§ | 2026-01-27 | 2043-09-08 | 0 | 31 |
| 12533343 | Method for preparing (−)-cibenzoline succinate | 🖼🧊📄§ | 2026-01-27 | 2039-09-20 | 0 | 31 |
| 12533352 | Analgesic therapeutic and method, 1-(3-4(((1R,3S,5S)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and salts thereof | 🖼🧊📄§ | 2026-01-27 | 2044-01-18 | 0 | 31 |
| 12533335 | Monoglyceride use in animals | 🖼🧊📄§ | 2026-01-27 | 2044-07-18 | 0 | 31 |
| 12534443 | Processes for preparing oxathiazin-like compounds | 🖼🧊📄§ | 2026-01-27 | 2044-05-06 | 0 | 31 |
| 12534514 | Biological and synthetic molecules inhibiting respiratory syncytial virus infection | 🖼🧊📄§ | 2026-01-27 | 2040-04-17 | 0 | 31 |
| 12534469 | Multi-cyclic IRAK and FLT3 inhibiting compounds and uses thereof | 🖼🧊📄§ | 2026-01-27 | 2041-12-15 | 0 | 31 |
| 12533383 | Method for producing cell aggregate including glial progenitor cells | 🖼🧊📄§ | 2026-01-27 | 2040-09-04 | 0 | 31 |
| 12533368 | Compositions for use in the reduction of pain and/or perception of pain in infants and young children | 🖼🧊📄§ | 2026-01-27 | 2040-12-04 | 0 | 31 |
| 12534732 | Therapeutic compounds for red blood cell-mediated delivery of an active pharmaceutical ingredient to a target cell | 🖼🧊📄§ | 2026-01-27 | 2042-11-18 | 0 | 31 |
| 12533365 | Fast absorbing trolamine salicylate formulations and compositions | 🖼🧊📄§ | 2026-01-27 | 2045-02-21 | 0 | 31 |
| 12534517 | Highly specific zika neutralizing human antibodies | 🖼🧊📄§ | 2026-01-27 | 2038-11-21 | 0 | 31 |
| 12533374 | Compositions and methods of use thereof | 🖼🧊📄§ | 2026-01-27 | 2041-04-30 | 0 | 31 |
| 12533362 | Methods for treating diseases associated with ciliopathies | 🖼🧊📄§ | 2026-01-27 | 2038-10-12 | 0 | 31 |
| 12534741 | Compositions and methods for treatment of neurological disorders | 🖼🧊📄§ | 2026-01-27 | 2043-07-19 | 0 | 31 |
| 12533379 | Application of TREM2hi macrophages in the preparation of drugs for the treatment of cardiac dysfunction | 🖼🧊📄§ | 2026-01-27 | 2042-11-06 | 0 | 31 |
| 12533334 | Compositions and methods for modulating equine fatty acid profiles | 🖼🧊📄§ | 2026-01-27 | 2044-06-17 | 0 | 31 |
| 12533409 | Compositions and methods for targeting mutant RAS | 🖼🧊📄§ | 2026-01-27 | 2040-01-24 | 0 | 31 |
| 12533393 | Vibrio cholerae protein for use against cancer | 🖼🧊📄§ | 2026-01-27 | 2040-10-09 | 0 | 31 |
| 12533421 | Methods for making multilayered vesicles | 🖼🧊📄§ | 2026-01-27 | 2042-02-16 | 0 | 31 |
| 12533378 | Treatment of adverse effects caused by atypical antipsychotics | 🖼🧊📄§ | 2026-01-27 | 2040-05-10 | 0 | 31 |
| 12534435 | Lipids and nanoparticle compositions thereof | 🖼🧊📄§ | 2026-01-27 | 2041-03-26 | 0 | 31 |